Active, not recruitingPhase 3NCT01674140
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Studying Rare malignant breast tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Mariana Chavez-MacGregor, MD, MScM.D. Anderson Cancer Center
- Intervention
- anastrozole(drug)
- Enrollment
- 1939 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2022
Study locations (20)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
- Alaska Regional Hospital, Anchorage, Alaska, United States
- Alaska Women's Cancer Care, Anchorage, Alaska, United States
- Anchorage Oncology Centre, Anchorage, Alaska, United States
- Katmai Oncology Group, Anchorage, Alaska, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
- Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
- University of Arizona Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01674140 on ClinicalTrials.govOther trials for Rare malignant breast tumor
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06255808Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorSeoul National University Hospital
- RECRUITINGNANCT06523452Laser Speckle Imaging During Breast ReconstructionRoyal Devon and Exeter NHS Foundation Trust
- RECRUITINGPHASE1NCT06239467First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerOnKure, Inc.
- ACTIVE NOT RECRUITINGPHASE1NCT06206837A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Pfizer
- ACTIVE NOT RECRUITINGNANCT06234488Multi-Institutional Transgender & Gender-Diverse Breast Cancer StudyMedical College of Wisconsin
- RECRUITINGPHASE2NCT05601440Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerCanadian Cancer Trials Group
- ENROLLING BY INVITATIONNANCT07206888Advanced Ultrasound Signal Processing of Suspicious Breast ImagesJohns Hopkins University
- ACTIVE NOT RECRUITINGPHASE3NCT01349322Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryRadiation Therapy Oncology Group